DR. PETER JOHN POMMERVILLE B.A., M.D., F.R.C.S.(C)

3066 Shelbourne Steet, Suite 315
Victoria, BC V8R 6T9

Medical Licence: # 309821 (Canada)/ #10303 (BC)

A. ACADEMIC DEGREES (1971-1984)

B.A. PRE-MEDICINE
University of Ottawa, Ottawa, Ontario, Canada 1974

DOCTOR OF MEDICINE
University of Ottawa, Ottawa, Ontario, Canada 1978

INTERNSHIP
Ottawa Civic Hospital, Ottawa, Ontario, Canada 1979
Christchurch Public Hospital, University of Otago, Christchurch, New Zealand 1980

RESIDENCY IN UROLOGY
University of Ottawa, Ottawa, Ontario, Canada 1983

FELLOW IN UROLOGY
University of British Columbia, Vancouver, British Columbia, Canada 1984

FELLOW OF THE ROYAL COLLEGE OF SURGEONS OF CANADA
Fellowship in Urology 1984

BOARD ELIGIBLE
American Board of Urology 1992

B. APPOINTMENTS and PRIVILEGES

* Royal Jubilee Hospital
* Victoria General Hospital
* Gorge Road Rehab Centre
* Victoria Out-Patient Clinic
* BC Cancer Agency

C. AFFILIATIONS AND ASSOCIATIONS

1985 - present Active Staff:
Vancouver Island Health Authority, Victoria, B.C.
Gorge Road Hospital, Royal Jubilee Hospital, Victoria General Hospital

1986 - 1987 Director:
Victoria Medical Society, Victoria, B.C.

1987 - 1990 Chief,
Section of Urology: Greater Victoria Hospital Society, Victoria, B.C.

1988 - 1991 Vice-Chief, Surgery:
Greater Victoria Hospital Society, Victoria, B.C.

1990 - 1991 Chair Q.A. Surgery:
Greater Victoria Hospital Society, Victoria, B.C.

1992 - 1993 Medical Director:
Prostate Treatment Centre, Victoria, B.C.

1992 - present Guest Lecturer:
University of Victoria - Department of Continuing Education
University of Victoria - Faculty of Nursing
University of B.C.- Department of Continuing Education
University of B.C.- Faculty of Pharmacy

1993 - 1998
Editorial Staff: The Canadian Journal of Urology
Medical Board: Prostate Cancer Support Group, Greater Victoria Hospital Society
Editorial Board: The Canadian Medical Association Journal

1994 - present Medical Staff:
Cancer Control Agency of B.C., Victoria Clinic

1995 - present C.M.E. Committee:
Capital Health Region, Victoria, B.C. (Royal Jubilee Hospital, Victoria General Hospital, Gorge Road Hospital)

1996 - present
Medical Advisor: V.I. Prostate Cancer Research Foundation, Victoria, B.C.
Medical Advisor: Interstitial Cystitis Association, Canada
Advisory Board: Merck Frosst, Canada

1997 - present
Board Member: Canadian Urological Association
Member: Clinical Guidelines Committee, Canadian Urological Association
Member: Clinical Studies Committee, Canadian Urological Association
Medical Advisor: Sexual Function Health Council of Canada, Canadian Urological Association
Advisory Board: Bioniche Inc., London, Ontario, Canada
Member: Consulting Staff of the B.C. Cancer Agency

1997 - 1998
President: Northwest Urological Society

1998 - present
Editorial Staff: Canadian Medical Association Journal

1998 - present
Advisory Board: Canadian Continence Foundation

1998 - 2001
Advisory Board: Canadian Urological Assication Representative to the Canadian Medical Association

1999 - present
Member: Canadian Andropause Society

1999 - present
Member: The International Society for The Study of the Aging Male

2000 – present
Principal Investigator Can-Med Clinical Research Inc.

2000 - present
Member Professional Advisory: The Canadian Continence Foundation

2000 - present
Member Medical Advisory Committee: The Vancouver Island Prostate Cancer Research Foundation

2000 - present
Reviewer: CMA Journal

2001 – present
Member Pharmacia Advisory Board:Detrol and Over Active Bladder

2001 – present
Member Bayer Advisory Board: ED Board and Vardenafil
UTI Board and CIPRO Once “A” Day Formulation

2001 – present
Member Pfizer Advisory Board: ED Board and Viagra (Educational Committee)

2001 – present
Member Eli Lilly Advisory Board: ED Board and Cialis

2001 – present
Member Solvay Pharma Advisory Board: Drug Council Research

2001 – present
Director CURC

2001 – present
Member Advisory Board Ditropan XL Regional Urology Board

2002 – present
Safety Program Course Conductor Canadian Hockey Association

2002 – present
Chair, Socio-economics & Manpower Canadian Urological Association Committee

2002 – present
Editorial Board Optimale –The men’s sexual health magazine

D. MEMBERSHIPS

* Canadian Urological Association
* Canadian Urological Association Oncology Group
* British Columbia Medical Association
* Canadian Medical Association
* Canadian Medical Protective Association
* Western Section American Urological Association
* American Urological Association
* Northwest Urological Society
* Association of Clinical Surgeons (Western Division)
* Society of Specialist Physicians & Surgeons of British Columbia
* Canadian Sexual Health Council
* Canadian Continence Foundation
* The International Society for The Study of the Aging Male
* Canadian Andropause society
* The Andropause Society
* European Association of Urology
* Canadian Urological Research Consortium
* Association De Médecine Sexuelle du Québec
* International Society for Sexual and Erectile Dysfunction Research
* Sexual Medicine Society of North America, Inc.
* Association of Clinical Research Professionals

E. PUBLICATIONS

Sullivan L, Casey RW, Pommerville PJ, Marich KW. Canadian experience with high intensity focused ultrasound for the treatment of BPH. Can J Urol. 1999 Jun;6(3):799-805.

Nickel JC, Johnston B, Downey J, Barkin J, Pommerville P, Gregoire M, Ramsey E.Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial. Urology. 2000 Sep 1;56(3):413-7.

Nickel JC, Fradet Y, Boake RC, Pommerville PJ, Perreault JP, Afridi SK, Elhilali MM. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). Proscar Safety Plus Efficacy Canadian Two year Study. CMAJ. 1996 Nov 1;155(9):1251-9.

Pommerville P, Futter NG, McKay DE, Desmarais R. The role of gonadal venography in the management of the adult with non-palpable undescended testis. Br J Urol. 1982 Aug;54(4):408-10.

Brock G, Gilbert RE, Hodges M, Jacobson W, Stuckey B. (Acknowledgement Pommerville P.) Optimal dosing with Sildenafil for treatment or erectile dysfunction. Can J Urol. submitted

Pommerville PJ. Emerging therapies for the management of erectile dysfunction. J. Sexual and reproductive Medicince. 2002 Vol2 Number 2: 80-86.

Pommerville PJ. The management of erectile dysfunction in the aging male. Geriatrics and Aging. 2002 Sept; Vol5, Number 7: 19-31

Craig Donatucci, Peter Pommerville, Craig Niederberger, Marc Thibonnier, Thomas Segerson, Kevin T. McVary, and Wayne G. Hellstrom. Vardenafil improved patient satisfaction with erection harness, orgasmic function, and sexual experience in men with erectile dysfunction. AUA (2002) Abstract (submitted)

Peter Pommerville, G. Brock, S. Carrier, M. Seger. Levitra™ (Vardenafil) efficacy and safety in the treatment of erectile dysfunction in men post radical prostatectomy. NWUS (2002) Abstract (submitted)

M. Greenspan, K. Matthews, P. Pommerville, L. Valiquette, and the Vardenafil Study Team. Levitra™ (Vardenafil) improved patient satisfaction with hardness, orgasmic function, and sexual experience in men with erectile dysfunction. CUC (2003) Abstract (submitted)
F. LECTURES and PRESENTATIONS

Science and Medicine Canada – Vancouver October 16,2002

* Diabetes and Erectile Dysfunction

Bayer Canada, Victoria October 15, 2002

* “Bugs that bug you” – talk on UTI’s and Prostatitis

ISSIR, Montreal September 26, 2002

* Clinical Profile of Apomorphine SL
* Evaluation and Management of ED: Emerging Therapies – Where do they fit?
* The Dynamics of the Cardivascular System and ED Therapy

G. CLINICAL RESEARCH TRIALS

Schering, Canada
- Flutomide
Hoechst-Roussel Canada Inc.
- Nilutamide
SmithKline Beecham Pharma Inc.
- Epristeride
- Androderm
Merck Frosst Canada Inc.
- Finasteride
Bioniche Inc.
- Cystistat
Zeneca Pharmaceuticals
- Casodex
AstraZeneca
- 7054IL/0054
- 7054IL/0044
Pfizer Canada Inc.
- Doxazosin
- Sildenafil
- A2841010 0026
- A1371047 – Darifenacin
- A1371042 - Darifenacin
Covance
- A1481127 – Female Sexual Arousal Disorder
Faulding
- BCG
Janssen-Ortho Inc.
- Liarozole 26, Liarozole 29
- Alprostadil
- Muse
Diagnostic Oncology CRO, Inc.
- ImmunoCyt
Glaxo Wellcome Inc.

- GI198745 (BPH)
GlaxoSmithKline
- Oral SB 223412
- ARI 40006
- SB389456-002
- 782528/002
- SB 782528-002
IBRD-Rostrum
- Apomorphine
Diagnocure
- Bladder Cancer
Focus Surgery
- High Intensity Focused Ultrasound
Coherent-AMT
- Holmium Laser Prostate Resection
Purdue Frederick
- Oxyblitynin
Technomed International
- Transurethral Microwave Thermal Therapy (Prostatron)
Influence
- In-Flow IDE
Pharmacia & Upjohn Inc.
- Tolterodine -
Bayer
- 100285
- 100249
- Vardenafil
Alza
- Elmiron
Praecis
- Lupron/Casodex vs Abarelix
Beckman Coulter/Hybritech
- PSA Blood Assay Test
Novartis
- Zoledronate
- VGP 42446
Amgen
- Abarelix
Sanofi~Synthelabo
- Alfusosin
- Altess
- Alf-X
Bioniche
- HIS 0609-0005
- HIS 0606-0104
- HIS 0604-9708
- HIS 0608-9708
Eli Lilly
- SBAV/SBAW
- LVAC
- LVBL
- H6D-MC-LVCE
- LVDJ
- B7A-MC-MBC1
- SBAM
- LVDR
- LVDC
MDS Pharma Services
- Apomorphine
Queen’s University
- Levofloxacin
Genyx
- Uryx
Abbott
- Atrasentan M00-211
- Atrasentan M00-244
- Atrasentan M00-258
- Atrasentan M01-304
- Uprima
- Atrasentan M01-366
American Medical Systems
- SPARC™